BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3836658)

  • 1. Evaluation of prophylactic postoperative 131I therapy for extended differentiated carcinoma of the thyroid gland.
    Nagahara K; Yoza T; Naito Y; Konishi J; Fujita N
    Auris Nasus Larynx; 1985; 12 Suppl 2():S67-71. PubMed ID: 3836658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective postoperative radioactive iodine treatment of thyroid carcinoma.
    McHenry C; Jarosz H; Davis M; Barbato AL; Lawrence AM; Paloyan E
    Surgery; 1989 Dec; 106(6):956-8; discussion 958-9. PubMed ID: 2588122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy for differentiated thyroid carcinoma.
    Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
    Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term course in differentiated thyroid gland carcinoma].
    Rösler H; Birrer A; Lüscher D; Kinser J
    Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current state of the treatment of thyroid cancer].
    Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
    Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
    Baranauskas ZL; Mamontov VV; Valutskas KK
    Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine therapy of thyroid disease.
    Beierwaltes WH
    Int J Rad Appl Instrum B; 1987; 14(3):177-81. PubMed ID: 3312117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic approach to differentiated carcinoma of the thyroid gland].
    Busnardo B
    Minerva Endocrinol; 1987; 12(1):69-73. PubMed ID: 3587203
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.
    Lin JD; Tsang NM; Huang MJ; Weng HF
    Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.
    Hundeshagen H
    Eur J Nucl Med; 1983; 8(12):541-5. PubMed ID: 6667704
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?
    Proye CA; Dromer DH; Carnaille BM; Gontier AJ; Goropoulos A; Carpentier P; Lefebvre J; Decoulx M; Wemeau JL; Fossati P
    World J Surg; 1992; 16(4):640-5; discussion 645-6. PubMed ID: 1384244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.
    Lin JD; Chao TC; Huang MJ; Weng HF; Tzen KY
    Am J Clin Oncol; 1998 Feb; 21(1):77-81. PubMed ID: 9499265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy?
    Zettinig G; Fueger BJ; Passler C; Kaserer K; Pirich C; Dudczak R; Niederle B
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):377-82. PubMed ID: 11940050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
    Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
    Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.